Bye-bye muscle biopsy, we have autoantibodies with us now
Muscle biopsy is generally considered the gold standard diagnostic tool for patients with presenting with features suggestive of idiopathic inflammatory myopathy. Muscle biopsy is however an invasive test, the histopathological findings can be influenced by previous treatment and not all patients wi...
Saved in:
Main Authors: | Victoria Riddell, Sarah L Tansley |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=6;spage=74;epage=80;aulast=Riddell |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of myositis-specific autoantibodies in personalized therapy
by: Anand N Malaviya, et al.
Published: (2018-01-01) -
Sporadic inclusion body myositis in the rheumatology clinic
by: Fernando Henrique Carlos de Souza, et al.
Published: (2020-01-01) -
Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry
by: Tatiana Cobo-Ibáñez, et al.
Published: (2025-01-01) -
Is polymyositis a rare or over-diagnosed entity? A descriptive follow-up study of patients initially admitted in a tertiary center with the diagnosis of polymyositis
by: Pablo Arturo Olivo Pallo, et al.
Published: (2020-01-01) -
The utility of muscle magnetic resonance imaging in idiopathic inflammatory myopathies: a scoping review
by: Julie J. Paik, et al.
Published: (2025-01-01)